Conan MedTech is leading the charge in developing a rapid Point-of-Care (POC) diagnostic test for mild Traumatic Brain Injury (mTBI), also known as a concussion. Our groundbreaking technology utilizes a non-invasive, novel saliva biomarker allowing patients to perform the test independently or by a cohort. This innovation facilitates quick and accurate diagnosis while empowering people to take proactive measures in managing their health.
Bayan A. Alturkestani, founder of Conan MedTech, received acclaim for her innovative work in concussion solutions, securing the 1st place at the 2019 SABIC entrepreneurship competition. In 2020-2021, she was honored with the Top 100 Healthcare Leaders award at the International Forum on Advancements in Healthcare in Las Vegas, highlighting her commitment to innovation in healthcare.
Backed by industry leaders, Conan MedTech has secured strategic investments from renowned entities including SOSV and various Angel Investors. This support fuels the company's mission to revolutionize healthcare, driving innovation and impactful solutions. Partner with us on this exciting journey towards a healthier future.
Conan MedTech emerged in 2020 with a visionary idea, now evolving into a trailblazer in concussion care.
Bayan A. AlturkestaniM.S in Biomedical Engineering from Cornell University and comes from previous background in concussion, TBI, CTE
Dania GiadduiM.S in Biotechnology from Thomas Jefferson University and comes from previous background in neuroscience.
Partner with Conan MedTech for pioneering concussion solutions to shape a safer tomorrow. Explore investment opportunities now!
We are currently in the development phase of a portable device using the latest in medical technology to be used by war veterans, athletes and students, independently or by a cohort, for real-time concussion detection.
